Learning Objectives:

  • Outline the clinical presentation and pathophysiology of NMOSD
  • Outline the imaging and laboratory findings in NMOSD
  • Outline the new treatment options for NMOSD
  • Compare Aquaporin-4 antibody (AQP4) and Myelin Oligodendrocyte Glycoprotein (MOG) antibody disease



Click here to complete today’s evaluation: https://ce.icep.wisc.edu/neurology-grand-rounds-20-22-eval-15135

Session date: 
02/21/2022 - 4:00pm to 5:00pm CST
Medical Foundation Centennial Bldg, Room #1220
1685 Highland Ave
Madison, WI 53705
United States
  • 1.00 AMA PRA Category 1 Credit
  • 1.00 University of Wisconsin–Madison Continuing Education Hours
    • 1.00 Approved for AMA PRA Category 1 Credit™

Please login or register to take this course.
Discloser List CME Internal Report